Evidence map›Paper›PMID 33392160›Full record

ArticleFrontiers in bioengineering and biotechnology2020

The Impact of Biomaterial Cell Contact on the Immunopeptidome.

Michael Ghosh, Hanna Hartmann, Meike Jakobi, Léo März, Leon Bichmann, Lena K Freudenmann, Lena Mühlenbruch, Sören Segan, Hans-Georg Rammensee, Nicole Schneiderhan-Marra and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michael GhoshNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Hanna HartmannNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Meike JakobiNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Léo MärzDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Leon BichmannDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Lena K FreudenmannDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Lena MühlenbruchDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Sören SeganNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Hans-Georg RammenseeDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Nicole Schneiderhan-MarraNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Christopher ShippNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Stefan StevanovićDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Thomas O JoosNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
University of Tübingen · DENatural and Medical Sciences Institute · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomaterials play an increasing role in clinical applications and regenerative medicine. A perfectly designed biomaterial should restore the function of damaged tissue without triggering an undesirable immune response, initiate self-regeneration of the surrounding tissue and gradually degrade after implantation. The immune system is well recognized to play a major role in influencing the biocompatibility of implanted medical devices. To obtain a better understanding of the effects of biomaterials on the immune response, we have developed a highly sensitive novel test system capable of examining changes in the immune system by biomaterial. Here, we evaluated for the first time the immunopeptidome, a highly sensitive system that reflects cancer transformation, virus or drug influences and passes these cellular changes directly to T cells, as a test system to examine the effects of contact with materials. Since monocytes are one of the first immune cells reacting to biomaterials, we have tested the influence of different materials on the immunopeptidome of the monocytic THP-1 cell line. The tested materials included stainless steel, aluminum, zinc, high-density polyethylene, polyurethane films containing zinc diethyldithiocarbamate, copper, and zinc sulfate. The incubation with all material types resulted in significantly modulated peptides in the immunopeptidome, which were material-associated. The magnitude of induced changes in the immunopeptidome after the stimulation appeared comparable to that of bacterial lipopolysaccharides (LPS). The source proteins of many detected peptides are associated with cytotoxicity, fibrosis, autoimmunity, inflammation, and cellular stress. Considering all tested materials, it was found that the LPS-induced cytotoxicity-, inflammation- and cellular stress-associated HLA class I peptides were mainly induced by aluminum, whereas HLA class II peptides were mainly induced by stainless steel. These findings provide the first insights into the effects of biomaterials on the immunopeptidome. A more thorough understanding of these effects may enable the design of more biocompatible implant materials using

Indexed as

biocompatibilitybiocompatibility assaybiomaterialsforeign body responsehost responseimmunopeptidomicsmass spectrometrymonocytes

Identifiers

PMID33392160
PMCPMC7773052
OpenAlexW3111306408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.